Gene Name |
estrogen receptor 2 (ER beta) |
tripartite motif containing 24 |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Diethylstilbestrol
- Raloxifene
- Tamoxifen
- Estradiol
- Trilostane
- Estramustine
- Genistein
- Para-Mercury-Benzenesulfonic Acid
- N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide
- 5-Alpha-Androstane-3-Beta,17beta-Diol
- 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol
- Estriol
- Estropipate
- 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
- 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE
- [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE
- 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL
- 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
- 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
- (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol
- 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
- 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
- 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE
- 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE
- 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL
- (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL
- (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
- (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
88 interactors:
AKAP13
AKT1
ARID5A
BCAS2
CALM1
CALM2
CALM3
CCNC
CDK8
DAP3
DDX17
DDX5
DDX54
DNTTIP2
EIF3I
EP300
ESR1
JMJD1C
KAT5
LCK
MAD2L1
MAPK1
MAPK11
MED1
MED10
MED12
MED14
MED16
MED17
MED20
MED21
MED23
MED24
MED6
MED7
MEOX2
MKNK2
MMS19
MSH2
NCOA1
NCOA2
NCOA3
NCOA6
NCOA7
NCOR1
NCOR2
NFKBIB
NOTCH2NL
NR0B1
NR0B2
NRIP1
OXT
PELP1
PIAS1
PIAS2
PIAS3
PLSCR1
PNRC1
PNRC2
PPARG
PPARGC1A
PPP5C
PRMT2
PSMC3IP
RBFOX2
RBM39
REXO4
RFX6
RXRA
SERPINH1
SMAD2
SMAD3
SMAD4
SMARCE1
SP1
SRA1
SRC
SREBF1
STAT5A
TRAM1
TRIM24
TRIM59
TRIP4
WIPI1
YWHAH
YWHAQ
ZBTB17
ZNHIT3
|
47 interactors:
AR
ATF4
BRCA1
BRD7
CBX1
CBX3
CBX5
ESR1
ESR2
FOSL1
GTF2E1
HIST1H3A
HIST1H3B
HIST1H3C
HIST1H3D
HIST1H3E
HIST1H3F
HIST1H3G
HIST1H3H
HIST1H3I
HIST1H3J
HNF4A
HSPA1A
NFE2L2
NR2F2
NR3C1
NR3C2
PGR
PML
PPARG
RARA
RNF141
RNF181
RXRA
STAT6
SUMO1
TAF11
TAF1B
TAF1C
TAF7
THRA
TRIM28
TRIM33
TRIM8
UBE2U
VDR
ZNF10
|
Entrez ID |
2100 |
8805 |
HPRD ID |
03390 |
04556 |
Ensembl ID |
ENSG00000140009
|
ENSG00000122779
|
Uniprot IDs |
F1D8N3
G3V5M5
Q0PTK2
Q7LCB3
Q92731
|
O15164
|
PDB IDs |
1L2J
1NDE
1QKM
1U3Q
1U3R
1U3S
1U9E
1X76
1X78
1X7B
1X7J
1YY4
1YYE
1ZAF
2FSZ
2GIU
2I0G
2JJ3
2NV7
2QTU
2YJD
2YLY
2Z4B
3OLL
3OLS
3OMO
3OMP
3OMQ
4J24
4J26
|
2YYN
3O33
3O34
3O35
3O36
3O37
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
25mg
acrosomes
bisphenol
bpa
compromises
disrupts
dosages
epididymis
esr1
fsh
fshb
gnrhr
gonadal
gonadotropin
hypogonadism
hypogonadotropic
hypothalamic
lh
lhb
luteinizing
nontoxic
pituitary
reestablish
reproductive
reserves
sperm
spermatogenesis
spermatozoa
transit
|
advance
aerobic
alongside
bromodomain
doi
ectopic
glycolysis
glycolytic
greatly
hmec
hmecs
homeodomain
ihmecs
immortalized
isogenic
july
mammoplasty
nude
onc
online
publication
reader
reprogramming
signature
subcutaneous
tricarboxylic
tripartite
tumorigenesis
viable
|
Tagcloud (Difference) ? |
25mg
acrosomes
bisphenol
bpa
compromises
disrupts
dosages
epididymis
esr1
fsh
fshb
gnrhr
gonadal
gonadotropin
hypogonadism
hypogonadotropic
hypothalamic
lh
lhb
luteinizing
nontoxic
pituitary
reestablish
reproductive
reserves
sperm
spermatogenesis
spermatozoa
transit
|
advance
aerobic
alongside
bromodomain
doi
ectopic
glycolysis
glycolytic
greatly
hmec
hmecs
homeodomain
ihmecs
immortalized
isogenic
july
mammoplasty
nude
onc
online
publication
reader
reprogramming
signature
subcutaneous
tricarboxylic
tripartite
tumorigenesis
viable
|
Tagcloud (Intersection) ? |
|